Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies
- 1 July 2004
- journal article
- Published by Elsevier in Clinical and Applied Immunology Reviews
- Vol. 4 (5) , 351-366
- https://doi.org/10.1016/j.cair.2004.04.002
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Lupus and desoxyribonucleaseLupus, 2003
- T cell autoimmunity to histones and nucleosomes is a latent property of the normal immune systemArthritis & Rheumatism, 2002
- Simultaneous Cytometric Analysis of (Auto)antigen-Reactive T and B Cell ProliferationImmunobiology, 2002
- Clinical Utility of Selected Disease Activity Markers in Patients with Systemic Lupus ErythematosusClinical Rheumatology, 2001
- Histone-containing Immune Complexes are to a Large Extent Responsible for Anti-dsDNA Reactivity in the Farr Assay of Active SLE PatientsJournal of Autoimmunity, 2000
- Fas‐induced apoptosis, and diseases caused by its abnormalityGenes to Cells, 1996
- Intrathymic Injection of Polynucleosomes Delays Autoantibody Production in BXSB MiceClinical Immunology and Immunopathology, 1996
- Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.Journal of Clinical Investigation, 1994
- The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence TestLupus, 1992
- Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1966